Detalhe da pesquisa
1.
Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms.
Eur J Nucl Med Mol Imaging
; 49(4): 1113-1126, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625828
2.
Vaccinia virus and peptide-receptor radiotherapy synergize to improve treatment of peritoneal carcinomatosis.
Mol Ther Oncolytics
; 29: 44-58, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37180034
3.
Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotide.
Eur J Nucl Med Mol Imaging
; 39(12): 1868-75, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22940856
4.
New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting.
Clin Cancer Res
; 14(7): 2019-27, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18381940
5.
Design, synthesis, and biological evaluation of somatostatin-based radiopeptides.
Chem Biol
; 13(10): 1081-90, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17052612
6.
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
J Nucl Med
; 47(3): 502-11, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16513620
7.
Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy.
Clin Cancer Res
; 11(3): 1136-45, 2005 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15709181
8.
Overexpression of HER-2 in MDA-MB-435/LCC6 Tumours is Associated with Higher Metabolic Activity and Lower Energy Stress.
Sci Rep
; 6: 18537, 2016 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26727049
9.
Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
J Nucl Med
; 46(12): 2097-103, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16330576
10.
Radiometallo-labeled peptides in tumor diagnosis and therapy.
Met Ions Biol Syst
; 42: 109-42, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15206101
11.
Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.
Mol Endocrinol
; 24(2): 436-46, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20051480
12.
Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties.
J Pharm Sci
; 99(6): 2839-53, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20091826
13.
Evaluation of available in vitro 99mTc-RBC labeling techniques: a Canadian perspective.
J Nucl Med Technol
; 42(4): 243-4, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25472511
14.
Influence of different spacers on the biological profile of a DOTA-somatostatin analogue.
Bioconjug Chem
; 18(1): 84-92, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17226960
15.
Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.
Proc Natl Acad Sci U S A
; 103(44): 16436-41, 2006 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-17056720
16.
DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.
Eur J Nucl Med Mol Imaging
; 30(10): 1338-47, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12937948
17.
68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.
Eur J Nucl Med Mol Imaging
; 32(6): 724, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15551131